EGFR and Pleural effusion: According to the inclusion criteria, we selected 77 patients with EGFR mutation status confirmed in the tumor tissue by histological examination from 218 patients with NSCLC with pleural effusion, and those diagnosed with tumor cells in pleural effusion for the study (35 EGFR mutants, 42 EGFR wild‐type).